UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1825-1835

2013

Volltextzugriff (PDF)

Scenarios of cost-savings associated with Oncotype DX® test-guided decisions for adjuvant chemotherapy in early breast cancer in Germany

Breast (Edinburgh), 2021-04, Vol.56, p.S33-S34

2021

Volltextzugriff (PDF)

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Cancer treatment and research communications, 2022, Vol.31, p.100519-100519, Article 100519

2022

Volltextzugriff (PDF)

Factors correlating with reexcision after breast-conserving therapy

European journal of surgical oncology, 2009-01, Vol.35 (1), p.32-37

2009

Volltextzugriff (PDF)

Entwicklungen der gynäkologischen Onkologie – Verbesserung der Versorgung auf vielen Ebenen

Gynäkologe (Berlin), 2014-09, Vol.47 (9), p.638-647

2014

Volltextzugriff (PDF)

Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients

European journal of surgical oncology, 2012-01, Vol.38 (1), p.44-51

2012

Volltextzugriff (PDF)

Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies

European journal of surgical oncology, 2007-02, Vol.33 (1), p.39-43

2007

Volltextzugriff (PDF)

S3-Leitlinie 2012 zur Mammakarzinomnachsorge

Gynäkologe (Berlin), 2012-06, Vol.45 (6), p.460-466

2012

Volltextzugriff (PDF)

BRCA1/2 testing in HER2- advanced breast cancer (ABC): Results from the European component of a multi-country real-world study

Annals of oncology, 2019-10, Vol.30, p.v99

2019

Volltextzugriff (PDF)

292P - BRCA1/2 testing in HER2- advanced breast cancer (ABC): Results from the European component of a multi-country real-world study

Annals of oncology, 2019-10, Vol.30, p.v99-v99

2019

Volltextzugriff (PDF)

PCN98 Scenarios of Cost-Savings Associated with Oncotype DX® Test - Guided Decisions for Adjuvant Chemotherapy in EARLY Breast Cancer in Germany

Value in health, 2020-12, Vol.23, p.S440-S440

2020

Volltextzugriff (PDF)

P038 - Scenarios of cost-savings associated with Oncotype DX® test-guided decisions for adjuvant chemotherapy in early breast cancer in Germany

Breast (Edinburgh), 2021-04, Vol.56, p.S33-S34

2021

Volltextzugriff (PDF)

317P Awareness of genomic testing among patients with breast cancer in Europe

Annals of oncology, 2023-10, Vol.34, p.S311-S311

2023

Volltextzugriff (PDF)

313P Real-world multi-country study of treatment trends among patients (pts) with HER2− BRCA1/2 mutated (BRCA1/2mut) advanced breast cancer (ABC)

Annals of oncology, 2020-09, Vol.31, p.S368-S368

2020

Volltextzugriff (PDF)

312P Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC)

Annals of oncology, 2020-09, Vol.31, p.S367-S368

2020

Volltextzugriff (PDF)

314P Real-world (RW) multi-country study of BRCA1/2 testing in adult patients (pts) with HER2−advanced breast cancer (ABC)

Annals of oncology, 2020-09, Vol.31, p.S368-S369

2020

Volltextzugriff (PDF)

1126P Budget impact of Oncotype DX test compared to further gene expression tests in patients with early breast cancer in Germany

Annals of oncology, 2021-09, Vol.32, p.S922-S922

2021

Volltextzugriff (PDF)

158P Patient (pt) demographics, treatment patterns (tx) and hematologic (heme) toxicities among pts with HER2− advanced breast cancer (ABC) and BRCA1/2 mutation(s) (BRCA1/2mut): A multi-country real-world (RW) study

Annals of oncology, 2020-05, Vol.31, p.S73-S73

2020

Volltextzugriff (PDF)

157P Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2- advanced breast cancer (ABC): Results from a multi-country real-world study

Annals of oncology, 2020-05, Vol.31, p.S72-S73

2020

Volltextzugriff (PDF)

166P Awareness and availability of routine germline BRCA1/2 (gBRCA1/2) mutation testing in patients (pts) with advanced breast cancer (ABC) in Germany

Annals of oncology, 2020-05, Vol.31, p.S75-S76

2020

Volltextzugriff (PDF)

356P Real-world effectiveness in subgroups of palbociclib + endocrine therapy in HR+/HER2- ABC patients: Interim results of the PERFORM study

Annals of oncology, 2024-09, Vol.35, p.S366-S366

2024

Volltextzugriff (PDF)

Risk and risk assessment for breast cancer: Molecular and clinical aspects

Maturitas, 2007-05, Vol.57 (1), p.56-60

2007

Volltextzugriff (PDF)

407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study

Annals of oncology, 2023-10, Vol.34, p.S353-S354

2023

Volltextzugriff (PDF)

PCN323 Health Status/Utilities in Adult Patients with Germline BRCA1/2 Mutated (GBRCA1/2MUT) HER2− Advanced Breast Cancer (ABC) Treated with POLY(ADP-RIBOSE) Polymerase Inhibitors (PARPI) Versus Chemotherapy in a Real World (RW) Setting

Value in health, 2020-12, Vol.23, p.S479-S479

2020

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)
Tagungsberichte
(2)

Sprache

Englisch
(40)
Deutsch
(11)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Humans
(12)
Life Sciences & Biomedicine
(12)
Female
(11)
Breast Cancer
(10)
Middle Aged
(8)
Oncology
(8)
Aged
(7)
Adult
(6)
Breast Neoplasms - Drug Therapy
(5)
Medicine
(5)
Medicine & Public Health
(5)
Biological And Medical Sciences
(4)
Breast Neoplasms - Pathology
(4)
Endocrinology
(4)
Gynecology
(4)
Hematology, Oncology And Palliative Medicine
(4)
Medical Sciences
(4)
Obstetrics/perinatology/midwifery
(4)
Reproductive Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(16)
Breast
(5)
Gynäkologe
(5)
Gynäkologie
(5)
European Journal Of Surgical Oncology
(3)
Value In Health
(2)
Anticancer Research
(1)
Cancer Treatment And Research Communications
(1)
Clinical Epileptology
(1)
Der Klinikarzt
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Scenarios of cost-savings associated with Oncotype DX® test-guided decisions for adjuvant chemotherapy in early breast cancer in Germany

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Factors correlating with reexcision after breast-conserving therapy

Entwicklungen der gynäkologischen Onkologie – Verbesserung der Versorgung auf vielen Ebenen

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients

Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies

S3-Leitlinie 2012 zur Mammakarzinomnachsorge

BRCA1/2 testing in HER2- advanced breast cancer (ABC): Results from the European component of a multi-country real-world study

292P - BRCA1/2 testing in HER2- advanced breast cancer (ABC): Results from the European component of a multi-country real-world study

PCN98 Scenarios of Cost-Savings Associated with Oncotype DX® Test - Guided Decisions for Adjuvant Chemotherapy in EARLY Breast Cancer in Germany

P038 - Scenarios of cost-savings associated with Oncotype DX® test-guided decisions for adjuvant chemotherapy in early breast cancer in Germany

317P Awareness of genomic testing among patients with breast cancer in Europe

313P Real-world multi-country study of treatment trends among patients (pts) with HER2− BRCA1/2 mutated (BRCA1/2mut) advanced breast cancer (ABC)

312P Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC)

314P Real-world (RW) multi-country study of BRCA1/2 testing in adult patients (pts) with HER2−advanced breast cancer (ABC)

1126P Budget impact of Oncotype DX test compared to further gene expression tests in patients with early breast cancer in Germany

158P Patient (pt) demographics, treatment patterns (tx) and hematologic (heme) toxicities among pts with HER2− advanced breast cancer (ABC) and BRCA1/2 mutation(s) (BRCA1/2mut): A multi-country real-world (RW) study

157P Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2- advanced breast cancer (ABC): Results from a multi-country real-world study

166P Awareness and availability of routine germline BRCA1/2 (gBRCA1/2) mutation testing in patients (pts) with advanced breast cancer (ABC) in Germany

356P Real-world effectiveness in subgroups of palbociclib + endocrine therapy in HR+/HER2- ABC patients: Interim results of the PERFORM study

Risk and risk assessment for breast cancer: Molecular and clinical aspects

407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study

PCN323 Health Status/Utilities in Adult Patients with Germline BRCA1/2 Mutated (GBRCA1/2MUT) HER2− Advanced Breast Cancer (ABC) Treated with POLY(ADP-RIBOSE) Polymerase Inhibitors (PARPI) Versus Chemotherapy in a Real World (RW) Setting

Suchergebnisse filtern